National Institute of Allergy and Infectious Diseases- SBIR-STTR

NIAID SBIR-STTR
CFDA 93.8SB Active Grant Cooperative Agreement

Program Funding

Annual program obligations reported to SAM.gov.

Latest annual funding (estimated)
$166.6M FY2026
$176.3M
FY24
$163.3M
FY25
$166.6M
FY26*
* estimated

Program Objective

Provide funding to conduct and support basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases.

Eligibility

Eligible Applicants

  • For-Profit Organization
  • Small Business Person
  • Nonprofit Organization

How to Apply

Award Procedure

Applicants submit the grant application in grants.gov following guidance provided in the Notice of Funding Opportunity (NOFO). Center for Scientific Review (CSR) assigns the application. A peer review process by Scientific Review Group (SRG) assigns an overall impact score. A second level peer review is done by NIAID’s advisory council which determines if there is concurrence with the initial peer review and evaluates program relevance, and fiscal considerations. NIAID selects proposals based on several factors including programmatic priorities/set-asides, budget availability for that fiscal year, and security risk as assessed by the HHS Due Diligence Program. The Council makes recommendations to NIAID leadership. After advisory council review NIAID program staff evaluates applications. NIAID officials under delegated HHS authority consider all factors and make funding decisions. The NIAID Grants Management Officer (GMO) issues a Notice of Award (NOA). The NOA is the legally binding document which obligates federal funds, specifies the approved budget and project period, establishes terms and conditions of the assistance. Only a GMO has authority to obligate Federal funds.

Decision Timeline

  • Approval: > 180 Days
  • Renewal interval: > 180 Days
  • Appeal: > 180 Days

Scientific Peer Review, Advisory Council Review, and final funding decision or disapproval can vary but typically ranges from 8-12 months.

Program details & compliance

Description

Small Business Innovation Research (SBIR) program expands and improves private sector participation in biomedical research. The SBIR Program intends to increase and facilitate private sector commercialization of innovations derived from Federal research and development. The Small Business Technology Transfer (STTR) program stimulates and fosters scientific and technological innovation with small business through collaboration with research institutions.

Mission Categories

Primary: Biology

Other categories:
Research and Development

Required Documentation

SBIR and STTR grants, applicant organization (small business concern) must present in a research plan an idea that has potential for commercialization and furnish evidence that scientific competence, experimental methods, facilities, equipment, and funds requested are appropriate to carry out the plan. Grant form SF424 is used to apply SBIR and STTR applications.

Reporting & Compliance

Audit Required
Yes — Ad-hoc
Records Retention
3 years

Applicable 2 CFR 200 Subparts

  • Subpart B — General Provisions
  • Subpart C — Pre-Federal Award Requirements
  • Subpart D — Post-Federal Award Requirements
  • Subpart E — Cost Principles
  • Subpart F — Audit Requirements

Contacts

Kevin Richardson — Financial Analyst
3017617870
5601 Fishers Lane Suite 5E48, Rockville, MD 20852
Data from SAM.gov Federal Assistance Listings. Source published: 2026-01-15. Spec v2.0. Last synced: 2026-05-30 02:32:39.